Docebo Inc.
DCBO
$29.32
-$1.06-3.49%
| Weiss Ratings | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B- | |||
| Rating Factors | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.54 | |||
| Price History | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.46% | |||
| 30-Day Total Return | -8.63% | |||
| 60-Day Total Return | -31.30% | |||
| 90-Day Total Return | -41.21% | |||
| Year to Date Total Return | -35.26% | |||
| 1-Year Total Return | -36.95% | |||
| 2-Year Total Return | -23.96% | |||
| 3-Year Total Return | -39.12% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -45.56% | |||
| 52-Week Low % Change | 12.77% | |||
| Price | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $53.86 | |||
| 52-Week Low Price | $26.00 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Nov 08, 2024 | |||
| Valuation | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 877.88M | |||
| Enterprise Value | 785.47M | |||
| Price/Earnings (TTM) | 34.09 | |||
| Earnings Per Share (TTM) | 0.86 | |||
| Earnings Per Share Growth | 997.19% | |||
| Price/Earnings To Growth | 0.03 | |||
| Price/Sales (TTM) | 4.18 | |||
| Price/Book (Q) | 15.36 | |||
| Enterprise Value/Revenue (TTM) | 3.62 | |||
| Price | $29.32 | |||
| Enterprise Value/EBITDA (TTM) | 36.77 | |||
| Enterprise Value/EBIT | 39.47 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 30.95M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 681 4601 | |||
| Address | 366 Adelaide Street West Toronto, ON M5V 1R9 | |||
| Website | www.docebo.com | |||
| Country | Canada | |||
| Year Founded | 2005 | |||
| Profitability | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.17% | |||
| Profit Margin | 12.32% | |||
| Management Effectiveness | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.13% | |||
| Return on Equity | 49.29% | |||
| Income Statement | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 216.93M | |||
| Total Revenue (TTM) | 216.93M | |||
| Revenue Per Share | $7.01 | |||
| Gross Profit (TTM) | 175.40M | |||
| EBITDA (TTM) | 21.36M | |||
| EBIT (TTM) | 19.90M | |||
| Net Income (TTM) | 26.74M | |||
| Net Income Avl. to Common (TTM) | 26.74M | |||
| Total Revenue Growth (Q YOY) | 15.75% | |||
| Earnings Growth (Q YOY) | 269.65% | |||
| EPS Diluted (TTM) | 0.86 | |||
| EPS Diluted Growth (Q YOY) | 313.26% | |||
| Balance Sheet | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 92.54M | |||
| Cash Per Share (Q) | $2.99 | |||
| Total Current Assets (Q) | 154.24M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 57.76M | |||
| Current Ratio (Q) | 1.199 | |||
| Book Value Per Share (Q) | $1.91 | |||
| Total Assets (Q) | 190.71M | |||
| Total Current Liabilities (Q) | 128.60M | |||
| Total Debt (Q) | 1.50M | |||
| Total Liabilities (Q) | 132.95M | |||
| Total Common Equity (Q) | 57.76M | |||
| Cash Flow | DCBO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.50M | |||
| Cash from Financing (TTM) | -6.84M | |||
| Net Change in Cash (TTM) | 20.59M | |||
| Levered Free Cash Flow (TTM) | 43.37M | |||
| Cash from Operations (TTM) | 29.25M | |||
